Inside informationEnglish
Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation.
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Carvolix
- Filed
- 15/06/2026, 17:45
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 008418_20260615